Vaccines, Adjuvants, and Delivery Systems

Science Communicator Platform

Share By

Vaccines, Adjuvants, and Delivery Systems Publisher

Keshavarzfathi M^{1, 2, 3} ; Rezaei N^{3, 4, 5}

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2018

Abstract

Vaccines have been used as a preventive modality against infectious disease for a long time. The application of vaccines to treat the diseases, which have interactions with the immune system, have revealed a new concept of immunotherapy, known as therapeutic vaccines. Many efforts have been made to utilize this modality in the most efficient way. To optimize the current vaccines, understanding the determinants such as selection of the appropriate antigens, combination of effective adjuvants, application of a delivery system, and administration through the proper route are necessary. In this chapter, we will discuss the mentioned determinants to prepare the background for extending the knowledge of vaccinology. © 2019 Nima Rezaei and Mahsa Keshavarz-Fathi Published by Elsevier Ltd All rights reserved.

Related Docs

View other Related Docs

1. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

2. D D a Strategies to Designing Chimeric Recombinant Vaccines, Journal of Applied Biotechnology Reports (2021)

3. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (11)

Mohammadreza Salehi (1)

Other Related Docs

4. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

5. Immunoinformatics: In Silico Approaches and Computational Design of a Multi-Epitope, Immunogenic Protein, International Reviews of Immunology (2019)

6. Combination Therapy, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

7. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

8. Delving Into Revolutionary Sars-Cov-2 Vaccine Approaches: Molecular and Virological Examinations; Principles of Sars-Cov-2 Vaccine Platform; [Adentrandose En Enfoques Revolucionarios De Vacunas Sars-Cov-2: Examenes Moleculares Y Virologicos; Principios De La Plataforma De Vacunas Sars-Cov-2], Vacunas (2024)

9. Computer-Assisted Multi-Epitopes T-Cell Subunit Covid-19 Vaccine Design, Biomedical and Biotechnology Research Journal (2021)

10. Genetic Vaccine for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

11. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

12. Delivery Systems for Leishmania Vaccine Development, Expert Review of Vaccines (2016)

13. Combination Therapy: Cancer Vaccines and Other Therapeutics, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

14. Review on Approved and Inprogress Covid-19 Vaccines, Iranian Journal of Pharmaceutical Research (2022)

15. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

16. Obstacles in the Development of Therapeutic Cancer Vaccines, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

17. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)

18. A Review of Virus-Like Particle-Based Sars-Cov-2 Vaccines in Clinical Trial Phases, Iranian Journal of Pharmaceutical Research (2022)

19. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)

20. Current Advances and Challenges in Mpox Vaccine Development: A Global Landscape, Therapeutic Advances in Vaccines and Immunotherapy (2025)

Style	Citing Format
MLA	Keshavarzfathi M, Rezaei N. "Vaccines, Adjuvants, and Delivery Systems." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, vol. , no. , 2018, pp. 45-59.
APA	Keshavarzfathi M, Rezaei N (2018). Vaccines, Adjuvants, and Delivery Systems. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), 45-59.
Chicago	Keshavarzfathi M, Rezaei N. "Vaccines, Adjuvants, and Delivery Systems." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives , no. (2018): 45-59.
Harvard	Keshavarzfathi M, Rezaei N (2018) 'Vaccines, Adjuvants, and Delivery Systems', Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), pp. 45-59.
Vancouver	Keshavarzfathi M, Rezaei N. Vaccines, Adjuvants, and Delivery Systems. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. 2018;():45-59.
BibTex	@article{ author = {Keshavarzfathi M and Rezaei N}, title = {Vaccines, Adjuvants, and Delivery Systems}, journal = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, volume = {}, number = {}, pages = {45-59}, year = {2018} }
RIS	TY - JOUR AU - Keshavarzfathi M AU - Rezaei N TI - Vaccines, Adjuvants, and Delivery Systems JO - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives VL - IS - SP - 45 EP - 59 PY - 2018 ER -

Science Communicator Platform

Authors

Abstract